A.B. Chopa et al. / Journal of Organometallic Chemistry 690 (2005) 3865–3877
3875
4
HRMS (EI): m/z Calc. for C21H27O6P (M+): 406.4124.
Found: 406.4126.
3JHH = 7.0 Hz; JHP = 0.9 Hz, 6 H); 13C NMR:
d
157.19 (Caryl), 150.67 (2JCP = 7.0 Hz, Caryl), 140.29
(Caryl), 138.95 (Caryl), 138.10 (Caryl), 134.41 (Caryl),
128.58 (CHaryl), 128.35 (CHaryl), 127.67 (CHaryl),
127.53 (CHaryl), 120.68 (3JCP = 4.7 Hz, CHaryl), 117.25
(CHaryl), 96.87 (CH), 65.00 (2JCP = 6.5 Hz, CH2), 62.46
(CH2), 30.78 (CH2), 25.62 (CH2), 19.18 (CH2), 16.49
(3JCP = 7.0 Hz, CH3); HRMS (EI): m/z Calc. for
C27H31O6P (M+): 482.5101. Found: 482.5112.
3.14. 20-Methoxybiphenyl-2-yl tetrahydro-2H-2-pyranyl
ether (32)
General procedure A was followed with the adjust-
ment of 20 mol% of Cl2Pd(PPh3)2. In addition 1.25
equiv of CuI, 13.8 equiv of CsF and a crystal of 2,6-
di-tert-butyl-4-methylphenol was added to DMF solu-
tion of 2-iodoanisol (1.20 mmol) to prepare the title
compound from 16 (1.00 mmol). The crude product
was purified by preparative TLC (eluent: hexane:EtOAc,
8:2) to give 32 (0.071 g, 0.25 mmol, 25%) as a pale yel-
3.17. 4-Methoxy-400-cyano-[1,10;40,100]terphenyl (41)
General procedure A was followed to prepare the title
compound by reaction of 40 (1.00 mmol) with 4-
iodobenzonitrile (1.20 mmol). The crude product was
purified by DCVC (eluent: hexane:EtOAc, 7:3) to give
41 (0.222 g, 0.779 mmol, 78%) as a white solid. M.p.
212–214 ꢁC; 1H NMR (DMSO-d6): d 7.83–7.74 (m,
4H), 7.68–7.57 (m, 4H), 7.56–7.49 (m, 2H), 6.94–6.85
(m, 2H), 3.65 (s, 3H); 13C NMR: d 159.61 (Caryl),
144.52 (Caryl), 140.49 (Caryl), 136.74 (Caryl), 131.93
(Caryl), 133.21 (CHaryl), 128.42 (CHaryl), 128.14 (CHaryl),
127.65 (CHaryl), 127.14 (CHaryl), 119.23 (CN), 114.86
(CHaryl), 110.28 (Caryl), 55.59 (CH3); MS (m/z, relative
intensity): 285 (100, M+), 270 (30, M+ ꢀ 15), 242 (23),
214 (5), 190 (2), 163 (1), 142 (7), 115 (4), 94 (2), 63 (2);
HRMS (EI): m/z Calc. for C20H15NO (M+): 285.3441.
Found: 285.3439.
1
low liquid. H NMR: d 7.34–6.84 (m, 8 H), 5.29 (m,
1H), 3.69 (s, 3H), 3.76 (m, 1H), 3.46 (m, 1H), 1.64–
1.32 (m, 6H); 13C NMR: d 156.00 (Caryl), 154.11 (Caryl),
132.87 (CHaryl), 131.68 (CHaryl), 129.71 (CHaryl), 129.62
(CHaryl), 127.51 (Caryl), 126.61 (Caryl), 122.58 (CHaryl),
121.34 (CHaryl), 117.76 (CHaryl), 112.08 (CHaryl), 95.09
(CH), 63.30 (CH2), 56.61 (CH3), 30.07 (CH2),
25,86 (CH2), 20.13 (CH2); MS (m/z, relative intensity):
284 (1, M+), 200 (100, M+-84), 185 (23), 169 (36),
157 (18), 139 (23), 128 (38), 115 (15); HRMS (EI):
m/z Calc. for C18H20O3 (M+): 284.3534. Found:
284.3531.
3.15. O,O-Diethyl O-40-methoxybiphenyl-4-yl phosphate
(36)
3.18. 1-Biphenyl-4-yl)naphthalene (45)
General procedure B was followed to prepare the title
compound by reaction of 21 (1.00 mmol) with O,O-
diethyl O-4-bromophenyl phosphate (1.20 mmol). The
crude product was purified by DCVC (eluent: hex-
ane:EtOAc, 7:3) to give 36 (0.245 g, 0.73 mmol, 73%)
General procedure A with the adjustment of 5 mol%
of Cl2Pd(PPh3)2 was followed to prepare the title com-
pound by reaction of 43 (1.00 mmol) with 1-bromo-
naphthalene (1.20 mmol). The crude product was
purified by DCVC (eluent: hexane:EtOAc, 9:1) to give
45 (0.196 g, 0.703 mmol, 70%) as a white solid. M.p.
139–41 ꢁC; 1H NMR: d 7.95–7.13 (m); 13C NMR: d
141.28 (Caryl), 140.55 (Caryl), 140.29 (Caryl), 140.20
(Caryl), 134.30 (Caryl), 132.08 (Caryl), 130.89 (CHaryl),
129.24 (CHaryl), 128.71 (CHaryl), 128.11 (CHaryl), 127.76
(CHaryl), 127.54(CHaryl), 127.39(CHaryl), 127.34(CHaryl),
126.47 (CHaryl), 126.44 (CHaryl), 126.20 (CHaryl), 125.80
(CHaryl); MS (m/z, relative intensity): 280 (100, M+), 202
(20), 138 (7), 98 (2), 77 (3), 51 (2); HRMS (EI): m/z Calc.
for C22H16(M+): 280.3682. Found: 280.3687.
1
as a pale yellow liquid. H NMR: d 7.59–7.46 (m, 4H),
7.35–7.24 (m, 2H), 7.06–6.95 (m, 2H), 4.34–4.19 (m,
3
4
4H), 3.86 (s, 3H), 1.39 (dt, JHH = 7.0, JHP = 0.9, 6H);
13C NMR: d 159.61 (Caryl), 150.21 (2JCP = 7.0 Hz, Caryl),
138.16 (Caryl), 133.21 (Caryl), 128.39 (CHaryl), 128.27
(CHaryl), 120.59 (3JCP = 4.7 Hz, CHaryl), 114.67 (CHaryl),
64.97 (2JCP = 5.8 Hz, CH2), 55.72 (CH3), 16.48
(3JCP = 6.4 Hz, CH3); HRMS (EI): m/z Calc. for
C17H21O5P (M+): 336.3221. Found: 336.3219.
3.16. 4-Diethoxyphosphinyl)oxy-400-tetrahydro-2H-2-
pyranyloxy-[1,10;40,100]terphenyl (39)
General procedure A was followed to prepare the title
compound by reaction of 38 (1.00 mmol) with O,O-
diethyl O-4-bromophenyl phosphate (1.20 mmol). The
crude product was purified by DCVC (eluent: hex-
ane:EtOAc, 6:4) to give 39 (0.193 g, 0.401 mmol, 40%)
as a white solid. M.p. 109–110 ꢁC; H NMR: d 7.62–
7.02 (m, 12H), 5.41 (m, 1H), 4.27–4.11 (m, 4H), 3.88
(m, 1H), 3.58 (m, 1H), 2.06–1.46 (m, 6H), 1.31 (dt,
3.19. 5-Biphenyl-4-yl)-2-bromopyridine (46)
General procedure B was followed to prepare the title
compound by reaction of 43 (1.00 mmol) with 2,5-dib-
romopyridine (1.20 mmol). Crystallization from cold
Et2O gave 0.124 g (0.405 mmol, 40%) of compound 46
as a pale yellow solid. m.p. >300 ꢁC; 1H NMR
(DMSO-d6): d 9.09–8.99 (m, 1 H); 8.58–8.21 (m, 4 H);
1